Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Sell
14,533
-4,686
-24% -$72.6K 0.04% 425
2026
Q1
$260K Buy
+19,219
New +$269K 0.06% 276
2025
Q4
Sell
-50,090
Closed -$496K 548
2025
Q3
$496K Buy
+50,090
New +$488K 0.09% 218

Other funds holding VTRS

111 Capital's VTRS Position: Q2 2026 in Review

111 Capital reduced its Viatris (VTRS) stake by 24% in Q2 2026, selling an estimated $72.6K and leaving 14,533 shares worth $231K. The position accounts for 0.04% of the portfolio, ranked #425.

111 Capital first reported a position in VTRS in Q3 2025 and has held it in 3 quarters since. The position peaked at $496K in Q3 2025. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • 111 Capital held 14,533 shares of Viatris worth $231K as of Q2 2026.
  • 111 Capital sold 4,686 Viatris shares in Q2 2026, an estimated $72.6K.
  • Viatris made up 0.04% of 111 Capital's portfolio in Q2 2026, its #425 holding.
  • 111 Capital first reported a position in Viatris in Q3 2025 and has held it in 3 quarters since.
  • 111 Capital's Viatris position peaked at $496K in Q3 2025.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.